AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DULOXETINE 30 Mg ;

18 registrations across 1 African market— 18 active

Markets with DULOXETINE 30 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Duxalta 30 mg
Delayed release hard gelatin capsules containing enteric coated pellets
🇪🇬EgyptSAJA Pharmaceuticals Egypt - SAJAactive
Nervalta 30mg
Hard Gelatin Capsules Containing Delayed Release Pellets
🇪🇬Egyptislamic company for pharmaceuticals,chemicals and medical appliances (pharco pharmaceuticalsactive
Duloxifutal 30 mg
Delayed release capsule containing enteric coated pellets
🇪🇬EgyptFUTURE PHARMACEUTICAL INDUSTRIES-EGYPTactive
Copadexitine 30 mg
Delayed Release Capsules containing enteric coated pellets
🇪🇬Egyptcopad egypt for trade and pharmaceutical industries (copad pharma)active
Wadiloxtin 30mg
Delayed Release Capsule
🇪🇬EgyptWadi El Neel Benta for Pharmaceuticals and Medical Devicesactive
Karbalta 30mg
Hard Gelatin Capsules Containing Delayed Release Pellets
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
Adwitine 30 mg
Hard Gelatin Capsules Containing Delayed Release Pellets
🇪🇬EgyptAdwiaactive
Duxnorzet 30 mg
delayed release hard gelatin capsule
🇪🇬EgyptZeta Pharma for Pharmaceutical Industries (Zeta Pharma)active
Seroloxetine 30 mg
Delayed Release Capsules containing enteric coated pellets
🇪🇬EgyptP and C Labs - Pellets and CR Productsactive
Nervalta 30mg
Hard Gelatin Capsules Containing Delayed Release Pellets
🇪🇬Egyptislamic company for pharmaceuticals,chemicals and medical appliances (pharco pharmaceuticalsactive
Copadexitine 30 mg
Delayed Release Capsules containing enteric coated pellets
🇪🇬Egyptcopad egypt for trade and pharmaceutical industries (copad pharma)active
Duxnorzet 30 mg
delayed release hard gelatin capsule
🇪🇬EgyptZeta Pharma for Pharmaceutical Industries (Zeta Pharma)active
Seroloxetine 30 mg
Delayed Release Capsules containing enteric coated pellets
🇪🇬EgyptP and C Labs - Pellets and CR Productsactive
Duxalta 30 mg
Delayed release hard gelatin capsules containing enteric coated pellets
🇪🇬EgyptSAJA Pharmaceuticals Egypt - SAJAactive
Duloxifutal 30 mg
Delayed release capsule containing enteric coated pellets
🇪🇬EgyptFUTURE PHARMACEUTICAL INDUSTRIES-EGYPTactive
Wadiloxtin 30mg
Delayed Release Capsule
🇪🇬EgyptWadi El Neel Benta for Pharmaceuticals and Medical Devicesactive
Karbalta 30mg
Hard Gelatin Capsules Containing Delayed Release Pellets
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
Adwitine 30 mg
Hard Gelatin Capsules Containing Delayed Release Pellets
🇪🇬EgyptAdwiaactive

DULOXETINE 30 Mg ; in Africa — Regulatory Overview

DULOXETINE 30 Mg ; is registered across 1 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 18 registrations, 18 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.